Latest filing published 25 Oct 2024 for 박셀바이오.
이준행: trading record in brief
이준행 discloses dealings in 박셀바이오 to DART (FSS). Between 5 April 2021 and 18 October 2024, the trades on record add up to 13 filings.
In open-market terms, that means 12 purchases on one side and 1 sale on the other. The amount is not disclosed for 13 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2024, the count stands at 5 purchases and 1 sale.
The 12 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 25 October 2024, reports an open-market purchase in 박셀바이오. Filings reach the DART (FSS) feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 이준행
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,015,877 sharesKRXDART:20241025000512Canonical exit: 23 Jan 2025 (T+90)
- 637,961 sharesKRXDART:20240531002827
- 2,015,877 sharesKRXDART:20240521000219Canonical exit: 19 Aug 2024 (T+90)
- 2,015,877 sharesKRXDART:20240521000226Canonical exit: 19 Aug 2024 (T+90)
- 2,015,877 sharesKRXDART:20240513000016Canonical exit: 11 Aug 2024 (T+90)
- 2,015,877 sharesKRXDART:20240510001055Canonical exit: 8 Aug 2024 (T+90)
- 2,015,877 sharesKRXDART:20231117000117Canonical exit: 15 Feb 2024 (T+90)
- 2,015,877 sharesKRXDART:20231031000505Canonical exit: 29 Jan 2024 (T+90)
- 2,015,877 sharesKRXDART:20231023000274Canonical exit: 21 Jan 2024 (T+90)
- 2,015,877 sharesKRXDART:20231006000565Canonical exit: 4 Jan 2024 (T+90)
- 2,015,877 sharesKRXDART:20220418000255Canonical exit: 17 Jul 2022 (T+90)
- 2,015,877 sharesKRXDART:20220411001015Canonical exit: 10 Jul 2022 (T+90)
- 2,015,877 sharesKRXDART:20210405002918Canonical exit: 4 Jul 2021 (T+90)
13 of 13 declarations